Ex vivo perfusion of human spleens maintains clearing and processing functions

Blood

Volumn 107, Issue 9, 2006, Pages 3745-3752

  Buffet, Pierre A ^a   Milon, Geneviève ^b   Brousse, Valentine ^b   Correas, Jean Michel ^b   Dousset, Bertrand ^b   Couvelard, Anne ^b   Kianmanesh, Reza ^b   Farges, Olivier ^b   Sauvanet, Alain ^b   Paye, François ^b   Ungeheuer, Marie Noëlle ^b   Ottone, Catherine ^b   Khun, Huot ^b   Fiette, Laurence ^b   Guigon, Ghislaine ^b   Huerre, Michel ^b   Mercereau Puijalon, Odile ^b   David, Peter H ^b  

^a Biomedical Research Team   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE;

ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG HALF LIFE; ERYTHROCYTE; EX VIVO STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ORGAN PERFUSION; PANCREAS RESECTION; PANCREAS TUMOR; PARASITEMIA; PARENCHYMA; PHAGOCYTOSIS; PLASMA CLEARANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPLEEN; SPLENECTOMY;

EID: 33646415898     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-10-4094     Document Type: Article

References (40)

1. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5:606-616.
2. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343-1360.
3. Hill J, Walsh RM, McHam S, Brody F, Kalaycio M. Laparoscopic splenectomy for autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia: a case series and review of the literature. Am J Hematol. 2004;75:134-138.
4. Wyler DJ. The spleen in malaria. In: Malaria and the red cell. London, United Kingdom: Pitman London (Ciba Foundation symposium 94); 1983: 98-116.
5. David PH, Hommel M, Miller LH, Udeinya IJ, Oligino LD. Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Natl Acad Sci U S A. 1983;80:5075-5079.
6. Steiniger B, Barth P. Microanatomy and function of the spleen. Adv Anat Embryol Cell Biol. 2000; 151:III-IX, 1-101.
7. Lucey BC, Boland GW, Maher MM, Hahn PF, Gervais DA, Mueller PR. Percutaneous nonvascular splenic intervention: a 10-year review. Am J Roentgenol. 2002;179:1591-1596.
8. Zeppa P, Vetrani A, Luciano L, et al. Fine needle aspiration biopsy of the spleen: a useful procedure in the diagnosis of splenomegaly. Acta Cytol. 1994;38:299-309.
9. Serjeant GR, Serjeant BE. Management of sickle cell disease: lessons from the Jamaican Cohort Study. Blood Rev. 1993;7:137-145.
10. Urban BC, Hien TT, Day NP, et al. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect Immun. 2005;73:1986-1994.
11. Groom AC, Schmidt EE, MacDonald IC. Microcirculatory pathways and blood flow in spleen: new insights from washout kinetics, corrosion casts, and quantitative intravital videomicroscopy. Scanning Microsc. 1991;5:159-173; discussion 173-174.
12. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med. 1992;327:1779-1784.
13. Looareesuwan S, Ho M, Wattanagoon Y, et al. Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med. 1987; 317:675-679.
14. Chotivanich K, Udomsangpetch R, Dondorp A, et al. The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria. J Infect Dis. 2000;182:629-633.
15. Chotivanich K, Udomsangpetch R, McGready R, et al. Central role of the spleen in malaria parasite clearance. J Infect Dis. 2002;185:1538-1541.
16. Newton PN, Chotivanich K, Chierakul W, et al. A comparison of the in vivo kinetics of Plasmodium falciparum ring-infected erythrocyte surface antigen-positive and -negative erythrocytes. Blood. 2001;98:450-457.
17. Dondorp AM, Pongponratn E, White NJ. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Trop. 2004;89:309-317.
18. Moore JM, Kumar N, Shultz LD, Rajan TV. Maintenance of the human malarial parasite, Plasmodium falciparum, in scid mice and transmission of gametocytes to mosquitoes. J Exp Med. 1995; 181:2265-2270.
19. McKenzie SE. Humanized mouse models of FcR clearance in immune platelet disorders. Blood Rev. 2002;16:3-5.
20. Bouharoun-Tayoun H, Noun G, Druilhe P, Nakhle C, Haddad N, Chamat S. Plasmodium falciparum: production of human antibodies specific for the MSP-3 protein in the Hu-SPL-SCID mouse. Exp Parasitol. 2004;108:47-52.
21. Ishihara C, Tsuji M, Hagiwara K, Hioki K, Arikawa J, Azuma I. Transfusion with xenogeneic erythrocytes into SCID mice and their clearance from the circulation. J Vet Med Sci. 1994;56:1149-1154.
22. Fagniez PL, Munoz-Bongrand N. [Vascular control during left splenopancreatectomy in cancer]. Ann Chir. 1999;53:632-634.
23. White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol. 2002;18:458-464.
24. Schnitzer B, Sodeman T, Mead ML, Contacos PG. Pitting function of the spleen in malaria: ultrastructural observations. Science. 1972;177:175-177.
25. Angus BJ, Chotivanich K, Udomsangpetch R, White NJ. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood. 1997;90:2037-2040.
26. Pabst R, Frohlich D, Trepel F. [An easily adaptable system for organ perfusion]. Bruns Beitr Klin Chir. 1974;221:482-485.
27. Perlmann H, Berzins K, Wahlgren M, et al. Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum. J Exp Med. 1984;159:1686-1704.
28. Barradell LB, Fitton A. Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs. 1995;50:714-741.
29. Pongponratn E, Riganti M, Harinasuta T, Bunnag D. Electron microscopic study of phagocytosis in human spleen in falciparum malaria. Southeast Asian J Trop Med Public Health. 1989;20:31-39.
30. Casper JT, Koethe S, Rodey, GE, Thatcher LG. A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood. 1976; 47:183-188.
31. Rogers DW, Serjeant BE, Serjeant GR. Early rise in the "pitted" red cell count as a guide to susceptibility to infection in childhood sickle cell anemia. Arch Dis Child. 1982;57:338-342.
32. Grover R, Wethers DL. Spleen dysfunction in hemoglobinopathies determined by pitted red cells. Am J Pediatr Hematol Oncol. 1988;10:340-343.
33. Chen LT. Microcirculation of the spleen: and open or closed circulation? Science. 1978;201:157-159.
34. Lutz HU. Innate immune and non-immune mediators of erythrocyte clearance. Cell Mol Biol (Noisy-le-grand). 2004;50:107-116.
35. Snow RW, Korenromp EL, Gouws E. Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk? Am J Trop Med Hyg. 2004;71: 16-24.
36. Bach O, Baier M, Pullwitt A, et al. Falciparum malaria after splenectomy: a prospective controlled study of 33 previously splenectomized Malawian adults. Trans R Soc Trop Med Hyg. 2005;99:861-867.
37. Garnham PC. Comments on biology of human malaria. Mil Med. 1966;131(suppl):961-962.
38. Boone KE, Watters DA. The incidence of malaria after splenectomy in Papua New Guinea. BMJ. 1995;311:1273.
39. Sabchareon A, Burnouf T, Ouattara D, et al. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg. 1991;45:297-308.
40. Heppner DG Jr, Kester KE, Ockenhouse CF, et al. Towards an RTS, S-based, multi-stage, multiantigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine. 2005;23:2243-2250.